Unlocking the mystery of preexisting drug resistance: Study sheds light on cancer evolution
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Jul 15, 2024
0
19
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Jul 15, 2024
0
19
A new paper from an interdisciplinary team at MUSC Hollings Cancer Center describes how the bacteria Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant ...
Jun 17, 2024
0
23
The legalization of cannabis and the popularity of its edible versions is having an unexpected effect: More seniors landing in emergency departments with overdoses.
May 21, 2024
0
67
Relapses in a common form of leukemia may be preventable following new research that has identified how the cancer develops resistance to first line treatments.
Apr 9, 2024
0
3
Harnessing a pervasive type of cellular messenger shows early experimental promise as a routine way of sampling and monitoring the body's response to prescription drug exposure.
Mar 5, 2024
0
15
Through study findings published in Cell Reports, a team of scientists at VCU Massey Cancer Center has discovered a previously unknown interaction between proteins that is responsible for supplying energy to tumor cells and ...
Sep 12, 2023
0
72
Researchers at University of Galway studying cell interactions in bowel cancer have identified innovative strategies to enhance how the body and drug treatments fight the disease.
May 11, 2023
0
36
A single-dose of the antiviral drug peginterferon lambda reduced by half the risk of hospitalization or a visit to the Emergency Department due to COVID-19, according to a study published today in the New England Journal ...
Feb 8, 2023
0
123
There are currently no effective treatments for the core symptoms of autism spectrum disorder (ASD), such as difficulties with socializing and communicating. A new study uses a computer-based protein interaction network to ...
Sep 12, 2022
0
291
Researchers at the University of California, Irvine and the Italian Institute of Technology have developed a new molecule, ALY101, that shows promising anti-cancer activity against a wide range of tumor cell types and in ...
Apr 6, 2022
0
65